A detailed history of Aspire Growth Partners LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Aspire Growth Partners LLC holds 3,156 shares of EW stock, worth $272,362. This represents 0.18% of its overall portfolio holdings.

Number of Shares
3,156
Previous 3,107 1.58%
Holding current value
$272,362
Previous $243 Million 1.01%
% of portfolio
0.18%
Previous 0.2%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 03, 2025

BUY
$73.75 - $81.83 $3,613 - $4,009
49 Added 1.58%
3,156 $245 Million
Q2 2025

Aug 13, 2025

SELL
$67.07 - $78.22 $4,292 - $5,006
-64 Reduced 2.02%
3,107 $243 Million
Q1 2025

May 14, 2025

SELL
$67.95 - $76.19 $1,902 - $2,133
-28 Reduced 0.88%
3,171 $238 Million
Q4 2024

Feb 13, 2025

BUY
$64.54 - $75.92 $206,463 - $242,868
3,199 New
3,199 $237 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $53.4B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Aspire Growth Partners LLC Portfolio

Follow Aspire Growth Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspire Growth Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspire Growth Partners LLC with notifications on news.